Completion of the combination between Novozymes and Chr. Hansen
January 29, 2024 – Company announcement no. 2
Please see attachment.
CONTACT INFORMATION
Investor Relations
Tobias Cornelius Bjorklund
+45 3077 8682
tobb@novozymes.com
Anders Enevoldsen
+45 5350 1453
adev@novozymes.com
Press Relations
Lina Danstrup
+45 3077 0552
lind@novozymes.com
Attachment
